MANNKIND CORP
MANNKIND CORP
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Developed Technology Rights | - | - | - | - | - | - | 1 | - | - | - | - | - | |||||
In Process Research And Development | - | - | 4 | - | - | - | 4 | - | - | - | - | - | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 53 | 53 | 75 | 127 | 57 | 47 | 46 | 62 | 97 | 193 | 238 | 83 | |||||
Short Term Investments | 58 | 81 | 96 | 133 | 122 | 134 | 151 | 189 | 151 | 107 | 57 | 58 | |||||
Accounts Receivable Net Current | 43 | 28 | 38 | 17 | 27 | 29 | 12 | 18 | 23 | 20 | 15 | 22 | |||||
Inventory Net | 44 | 49 | 35 | 27 | 28 | 29 | 28 | 27 | 25 | 26 | 29 | 27 | |||||
Prepaid Expense And Other Assets Current | 47 | 40 | 47 | 54 | 44 | 34 | 31 | 31 | 30 | 36 | 35 | 36 | |||||
Assets Current | 246 | 251 | 292 | 359 | 279 | 274 | 268 | 328 | 326 | 383 | 373 | 226 | |||||
Restricted Cash | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | |||||
Long Term Investments | - | - | 5 | 26 | 22 | 17 | 5 | 17 | 13 | 4 | 7 | 3 | |||||
Property Plant And Equipment Net | 85 | 83 | 82 | 83 | 83 | 84 | 85 | 85 | 85 | 84 | 84 | 80 | |||||
Goodwill | 68 | 68 | 68 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Intangible Assets Net Excluding Goodwill | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 1 | 1 | 1 | 1 | |||||
Other Assets Noncurrent | 17 | 22 | 20 | 19 | 20 | 28 | 27 | 26 | 16 | 7 | 7 | 8 | |||||
Assets | 732 | 744 | 792 | 495 | 412 | 410 | 394 | 464 | 444 | 481 | 475 | 320 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 11 | 16 | 9 | 7 | 10 | 5 | 7 | 6 | 10 | 7 | 10 | 17 | |||||
Accrued Liabilities Current | 61 | 59 | 65 | 31 | 31 | 40 | 40 | 37 | 41 | 42 | 42 | 32 | |||||
Finance Lease Liability Current | - | - | - | - | - | - | - | - | - | 10 | 10 | 10 | |||||
Convertible Notes Payable Current | - | - | 36 | 36 | 36 | 36 | - | - | - | - | - | - | |||||
Business Combination Contingent Consideration Liab… | 34 | 24 | 21 | - | - | - | - | - | - | - | - | - | |||||
Contract With Customer Liability Current | 11 | 12 | 15 | 10 | 11 | 12 | 12 | 7 | 7 | 8 | 9 | 4 | |||||
Liabilities Current | 143 | 135 | 171 | 109 | 112 | 116 | 82 | 72 | 80 | 100 | 104 | 96 | |||||
Contract With Customer Liability Noncurrent | 37 | 39 | 40 | 48 | 45 | 47 | 51 | 65 | 66 | 68 | 70 | 69 | |||||
Operating Lease Liability Noncurrent | 10 | 10 | 11 | 10 | 11 | 11 | 12 | 12 | 3 | 4 | 4 | 4 | |||||
Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 94 | 94 | 94 | |||||
Convertible Long Term Notes Payable | - | - | - | - | - | - | 36 | 228 | 228 | 227 | 227 | 226 | |||||
Business Combination Contingent Consideration Liab… | - | 5 | 5 | - | - | - | - | - | - | - | - | - | |||||
Long Term Loans Payable | 319 | 319 | 318 | 73 | - | - | - | - | - | - | - | - | |||||
Liabilities | 800 | 804 | 843 | 539 | 467 | 469 | 473 | 674 | 670 | 711 | 721 | 572 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Additional Paid In Capital Common Stock | 3,161 | 3,150 | 3,142 | 3,132 | 3,129 | 3,126 | 3,119 | 2,996 | 2,992 | 2,986 | 2,981 | 2,976 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | 0 | 0 | 1 | 1 | 1 | 1 | - | - | - | 0 | |||||
Retained Earnings Accumulated Deficit | -3,232 | -3,213 | -3,196 | -3,180 | -3,188 | -3,189 | -3,202 | -3,209 | -3,221 | -3,219 | -3,229 | -3,231 | |||||
Stockholders Equity | -67 | -59 | -51 | -45 | -55 | -59 | -79 | -210 | -226 | -230 | -246 | -252 | |||||
Liabilities And Stockholders Equity | 732 | 744 | 792 | 495 | 412 | 410 | 394 | 464 | 444 | 481 | 475 | 320 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | |||||
Common Stock Shares Issued | 310 | 309 | 308 | 307 | 306 | 304 | 303 | 276 | 274 | 271 | 270 | 270 | |||||
Shares Outstanding | 310 | 309 | 308 | 307 | 306 | 304 | 303 | 276 | 274 | 271 | 270 | 270 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.90% | 16.29% | 16.01% | - | - | - | - | - | - | - | - | - |
| 2025 | -10.37% | -18.79% | -12.31% | 32.28% | 59.37% | 53.03% | -11.72% | -4.46% | -9.90% | -23.77% | -12.35% | -4.63% |
| 2024 | 6.14% | 18.64% | 32.95% | 24.95% | 23.75% | 30.54% | -8.25% | -7.71% | -18.40% | -4.57% | -17.00% | -20.11% |
| 2023 | - | - | - | 0.65% | -10.22% | -15.00% | -0.79% | -4.21% | -11.84% | 30.16% | 10.58% | 21.43% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.72 | 1.87 | 1.70 | 3.29 | 2.50 | 2.36 | 3.28 | 4.54 | 4.07 | 3.84 | 3.59 | 2.34 | |||||
| Quick Ratio | 1.08 | 1.20 | 1.23 | 2.54 | 1.84 | 1.82 | 2.55 | 3.74 | 3.39 | 3.21 | 2.98 | 1.69 | |||||
| Working Capital | 102.81M | 116.60M | 120.55M | 249.71M | 167.20M | 157.80M | 186.47M | 255.56M | 245.93M | 283.21M | 269.27M | 129.20M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -11.90 | -13.58 | -16.53 | -12.10 | -8.48 | -8.00 | -6.00 | -3.21 | -2.97 | -3.09 | -2.93 | -2.27 | |||||
| Interest Coverage TTM | 0.33 | 0.89 | 2.81 | 9.29 | 8.06 | 5.56 | 6.06 | 4.12 | 3.28 | 2.10 | 0.57 | -0.66 | |||||
| Debt Ratio | 1.09 | 1.08 | 1.06 | 1.09 | 1.13 | 1.14 | 1.20 | 1.45 | 1.51 | 1.48 | 1.52 | 1.79 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.69 | 0.62 | 0.59 | 0.65 | 0.71 | 0.67 | 0.66 | 0.68 | 0.66 | 0.58 | 0.52 | 0.57 | |||||
| Days Sales Outstanding TTM | 32.62 | 28.85 | 26.24 | 20.69 | 30.54 | 29.93 | 17.07 | 27.32 | 37.57 | 32.20 | 29.08 | 46.84 | |||||
| Receivables Turnover TTM | 11.19 | 12.65 | 13.91 | 17.64 | 11.95 | 12.19 | 21.38 | 13.36 | 9.71 | 11.34 | 12.55 | 7.79 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.14 | -0.08 | 0.02 | 0.09 | 0.11 | 0.09 | 0.10 | 0.08 | 0.04 | 0.03 | -0.04 | -0.10 | |||||
| Free Cash Flow Per Share TTM | -0.06 | 0.04 | 0.04 | 0.14 | 0.09 | 0.07 | 0.12 | 0.10 | 0.07 | 0.01 | -0.03 | -0.12 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 83.56% | 84.78% | 82.47% | 88.00% | 84.10% | 80.46% | 79.27% | 75.16% | 77.63% | 79.52% | 78.94% | 94.26% | |||||
| Operating Profit Margin TTM | 2.34% | 4.11% | 11.12% | 23.26% | 22.15% | 26.26% | 25.42% | 20.19% | 18.64% | 13.98% | 4.36% | -6.78% | |||||
| Net Profit Margin TTM | -11.08% | -6.63% | 1.68% | 9.32% | 10.87% | 10.12% | 9.66% | 8.07% | 4.73% | 3.78% | -6.00% | -17.72% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 30.46% | 21.23% | 22.23% | 17.44% | 21.48% | 32.50% | 43.50% | 51.35% | 57.08% | 74.92% | 99.42% | 131.61% | |||||
| Net Income Growth (1Y) | -232.98% | -179.41% | -78.75% | 35.55% | 179.42% | 254.85% | -331.09% | -168.93% | -124.74% | -111.92% | -86.34% | -67.92% | |||||
| EPS Growth (1Y) | -231.16% | -178.17% | -80.92% | 21.49% | 150.19% | 216.12% | -324.86% | -167.36% | -124.07% | -111.64% | -86.85% | -69.04% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -30.20 | -31.58 | 295.58 | 56.36 | 34.77 | 50.69 | 63.96 | 80.20 | 121.43 | 144.30 | -81.41 | -35.47 | |||||
| P/B TTM | -19.60 | -12.76 | -33.97 | -36.98 | -20.72 | -26.04 | -22.39 | -8.24 | -6.31 | -5.33 | -3.95 | -4.41 | |||||
| P/S TTM | 3.35 | 2.09 | 4.97 | 5.25 | 3.78 | 5.13 | 6.18 | 6.47 | 5.74 | 5.45 | 4.89 | 6.29 | |||||
| Market Cap | 1.32B | 755.25M | 1.73B | 1.65B | 1.14B | 1.53B | 1.76B | 1.73B | 1.43B | 1.22B | 971.93M | 1.11B | |||||
| Enterprise Value | 1.26B | 702.42M | 1.69B | 1.56B | 1.12B | 1.52B | 1.75B | 1.90B | 1.56B | 1.36B | 1.06B | 1.36B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -18.14M | 13.15M | 13.69M | 43.39M | 28.79M | 21.82M | 32.82M | 28.87M | 18.24M | 3.10M | -8.35M | -31.62M | |||||
| Net Debt | -52.93M | -52.83M | -38.60M | -91.17M | -20.84M | -11.20M | -10.29M | 165.74M | 131.12M | 138.02M | 92.50M | 247.59M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
MANNKIND CORP (MNKD) — SEC Financial Statements & Analysis
MANNKIND CORP (MNKD) is a pharmaceutical preparations company, incorporated in DE. MANNKIND CORP trades on Nasdaq as: MNKD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MANNKIND CORP reported a 30.46% year-over-year revenue growth, a Gross Profit Margin of 83.56% (TTM), a Debt-to-Equity ratio of -11.90x, a Price-to-Sales (P/S) ratio of 3.35x (TTM), a Price-to-Book (P/B) ratio of -19.60x (TTM), at a market cap of $1.32B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 30.46%
- Gross Profit Margin TTM
- 83.56%
- Debt To Equity
- -11.90x
- P/S TTM
- 3.35x
- P/B TTM
- -19.60x
- Market Cap
- $1.32B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MANNKIND CORP in?
MANNKIND CORP (MNKD) operates in the Pharmaceutical Preparations industry.
What is MNKD's market cap?
MANNKIND CORP (MNKD) has a market capitalization of $1.32B as of 2026-06-30.
What exchange does MNKD trade on?
MANNKIND CORP (MNKD) trades on the Nasdaq.
Where is MANNKIND CORP incorporated?
MANNKIND CORP is incorporated in DE.